Humacyte, Inc. (HUMA) stock
HUMANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.59+0.00 (+0.29%)
Close on Nov 11, 2026Market cap $164.37MP/E –Yield –
Humacyte enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Humacyte's enterprise value was $84.47M on Nov 11, 2026, against $194.59M a year earlier. Over the last 5 years it ranged from $34.33M to $1.01B, with a median of $188.38M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $84.47M | -36.4% |
| 2025 | Dec 31, 2025 | $132.72M | -75.2% |
| 2024 | Dec 31, 2024 | $534.28M | +176.1% |
| 2023 | Dec 29, 2023 | $193.49M | +322.1% |
| 2022 | Dec 30, 2022 | $45.84M | -90.9% |
| 2021 | Dec 31, 2021 | $506.33M | – |
See a number that looks wrong?